do-me/EUR-LEX huggingface dataset:
Prior notification of a concentration (Case M.9599 — Cobepa/Socotec) Candidate case for simplified procedure (Text with EEA relevance) 2019/C 371/09
Date: 2019-11-04
Institutions: Directorate-General for Competition, European Commission
Subjects: approval, economic concentration, investment company, merger control, testing








C_2019371EN.01001801.xml










4.11.2019   


EN


Official Journal of the European Union


C 371/18






Prior notification of a concentration
(Case M.9599 — Cobepa/Socotec)
Candidate case for simplified procedure
(Text with EEA relevance)
(2019/C 371/09)

1.   
On 25 October 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Cobepa SA (‘Cobepa’, Belgium), controlled by Vedihold SA (Luxembourg),










—


The Socotec Group (‘Socotec’, France).




Cobepa acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Socotec.
The concentration is accomplished by way of contract.


2.   
The business activities of the undertakings concerned are:






—


for Cobepa: a privately-held investment company centred around two main types of investments: growth capital investments and buy-out transactions,










—


for Socotec: offers range of testing, inspection and compliance services for activities such as construction, infrastructure, building management and industrial equipment.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.9599 — Cobepa/Socotec
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration (Case M.9597 — Cinven/Stichting Barentz Beheer/Barentz) Candidate case for simplified procedure (Text with EEA relevance) 2019/C 371/07
Date: 2019-11-04
Institutions: Directorate-General for Competition, European Commission
Subjects: adjuvant, distributor, economic concentration, food additive, foundation, investment company, merger control








C_2019371EN.01001401.xml










4.11.2019   


EN


Official Journal of the European Union


C 371/14






Prior notification of a concentration
(Case M.9597 — Cinven/Stichting Barentz Beheer/Barentz)
Candidate case for simplified procedure
(Text with EEA relevance)
(2019/C 371/07)

1.   
On 25 October 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


Cinven Capital Management (VI) Genera Partner Limited (‘Cinven’, Guernsey),










—


Stichting Barentz Beheer (‘the Foundation’, Netherlands),










—


H.L. Barentz B.V. (‘Barentz’, Netherlands).




Cinven and the Foundation acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control over Barentz.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


for Cinven: private equity business engaged in the provision of investment management and investment advisory services to a number of investment funds. Cinven controls a number of portfolio companies which are active in a variety of sectors across a range of jurisdictions,










—


for the Foundation: Dutch non-profit foundation (stichting). Its sole purpose, is to support and further develop the business of Barentz,










—


for Barentz: distribution of ingredients and additives for the food, pharmaceutical and cosmetics, chemical and animal nutrition industries.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.9597 — Cinven/Stichting Barentz Beheer/Barentz
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email:COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.
Commission Implementing Regulation (EU) 2019/1877 of 4 November 2019 approving amendments to the specification for a Protected Designation of Origin or a Protected Geographical Indication (Valle d’Itria (PGI))
Date: 2019-11-04
Institutions: Directorate-General for Agriculture and Rural Development, European Commission
Subjects: Apulia, Italy, designation of origin, labelling, product designation, red wine, rosé wine, sparkling wine, white wine








L_2019290EN.01000301.xml










11.11.2019   


EN


Official Journal of the European Union


L 290/3








            COMMISSION IMPLEMENTING REGULATION (EU) 2019/1877
of 4 November 2019
         
approving amendments to the specification for a Protected Designation of Origin or a Protected Geographical Indication (‘Valle d’Itria’ (PGI))


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007 (1), and in particular Article 99 thereof,

Whereas:







(1)


The Commission has examined the application for the approval of amendments to the specification for the Protected Geographical Indication ‘Valle d’Itria’, sent by Italy in accordance with Article 105 of Regulation (EU) No 1308/2013.












(2)


The Commission has published the application for the approval of the amendments to the specification in the Official Journal of the European Union, as required by Article 97(3) of Regulation (EU) No 1308/2013 (2).












(3)


No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013.












(4)


The amendments to the specification should therefore be approved in accordance with Article 99 of Regulation (EU) No 1308/2013.












(5)


The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of the Agricultural Markets,





HAS ADOPTED THIS REGULATION:



Article 1
The amendments to the specification published in the Official Journal of the European Union regarding the name ‘Valle d’Itria’ (PGI) are hereby approved.


Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.




This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 4 November 2019.


For the Commission,


On behalf of the President,

Phil HOGAN
            

Member of the Commission






(1)  
            OJ L 347, 20.12.2013, p. 671.

(2)  
            OJ C 171, 20.5.2019, p. 6.
Case T-736/19: Action brought on 4 November 2019 — HA v Commission
Date: 2019-11-04
Institutions: General Court
Subjects: European official, allowances and expenses, health expenditure, medical device, respiratory disease








C_2019432EN.01007001.xml










23.12.2019   


EN


Official Journal of the European Union


C 432/70






Action brought on 4 November 2019 — HA v Commission
(Case T-736/19)
(2019/C 432/80)
Language of the case: French

Parties


Applicant: HA (represented by S. Kreicher, lawyer)

Defendant: European Commission

Form of order sought

The applicant claims that the General Court should:






—


admit the present action as procedurally valid;










—


declare it to be well founded;










—


consequently, annul the decision of the Appointing Authority dated 13 August 2019, notified on 24 August 2019, in response to the applicant’s claim of 14 April 2019 (No R/249/19);










—


order the European Commission to pay all the costs and expenses of the proceedings.





Pleas in law and main arguments

In support of the action, the applicant relies on a single plea in law, alleging infringement of the legal and regulatory provisions applicable and, in particular, Commission Decision C(2007)3195 of 2 July 2007 laying down general implementing provisions for the reimbursement of medical expenses, in so far as the contested decision set a ceiling for reimbursement of EUR 3 100.00 for the rental of equipment for the treatment of sleep apnoea for the period from 1 March 2019 to 29 February 2024, whereas the aforementioned Decision does not set any maximum reimbursable amount in the event of rental for a period of use that is equal to or greater than three months.